Ignite Creation Date:
2024-05-06 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 12:54 PM
Study NCT ID:
NCT03683810
Status:
UNKNOWN
Last Update Posted:
2022-09-06
First Post:
2018-09-24
Brief Title:
The Effectiveness of Lactoferrin in the Management of Treatment-induced Anemia
Sponsor:
Cyprus University of Technology
Organization:
Cyprus University of Technology
Study Overview
Official Title:
The Effectiveness of Lactoferrin in the Management of Treatment-induced Anemia in Hematological Patients
Status:
UNKNOWN
Status Verified Date:
2022-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This will be a randomised control trial designed to test the effectiveness of lactoferrin in the management of treatment-induced anemia in patients with hematological malignancies
Detailed Description:
Chemotherapy induced anemia CIA is a common adverse event in cancer patients reported to occur in 20-60 whilst the resulting low hemoglobin level is associated with impaired quality of life Lactoferrin LF is a non-haem iron-binding protein that is part of the transferrin protein family along with serum transferrin ovotransferrin melanotransferrin and the inhibitor of carbonic anhydrase whose function is to transport iron in blood serum
The aim of the study is to test the effectiveness of LF along with standard care in the management of treatment-induced anemia
The aim of the study is to test the effectiveness of LF along with standard care in the management of treatment-induced anemia
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None